Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:50 AM
Ignite Modification Date:
2025-12-25 @ 4:50 AM
NCT ID:
NCT00051818
Eligibility Criteria:
Inclusion Criteria
* HIV-1 positive
* HIV RNA \< 500 copies/ml on a regimen of two nucleoside reverse transcriptase inhibitors (NRTIs) and either one protease inhibitor (PI) or one nonnucleoside reverse transcriptase inhibitor (NNRTI) for 6 months prior to study entry - HIV RNA \< 50 copies/ml at study screening
* CD4 \> 400 cells/mm3 with CD4 nadir of \> 100 cells/mm3
* Agree to Medication Event Monitoring System monitoring of one component of antiretroviral regimen
* HIV-1 viral load \>10,000 copies/ml at any time prior to initiating the current uninterrupted HAART regimen
* Willing to abstain from all immunomodulatory drugs during the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
17 Years
Study:
NCT00051818
Study Brief:
Protocol Section:
NCT00051818